Last 83.50 GBp
Change Today -0.25 / -0.30%
Volume 65.1K
MXF On Other Exchanges
As of 7:35 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

medicx fund ltd (MXF) Snapshot

83.25 GBp
Previous Close
83.75 GBp
Day High
83.75 GBp
Day Low
83.25 GBp
52 Week High
01/8/14 - 87.00 GBp
52 Week Low
10/17/14 - 77.00 GBp
Market Cap
Average Volume 10 Days
Shares Outstanding
5.80 GBp
Dividend Yield
Current Stock Chart for MEDICX FUND LTD (MXF)

Related News

No related news articles were found.

medicx fund ltd (MXF) Related Businessweek News

No Related Businessweek News Found

medicx fund ltd (MXF) Details

MedicX Fund specializes in real estate fund investments. The fund seeks to invest in infrastructure, modern purpose-built primary healthcare properties and financing the construction of NHS doctors' surgeries. It primarily invests in United Kingdom.

Founded in 2006

medicx fund ltd (MXF) Top Compensated Officers

Chief Executive Officer of MedicX Adviser Ltd...
Total Annual Compensation: --
Chief Financial Officer of Medicx Adviser Ltd
Total Annual Compensation: --
Non-Executive Chairman and Member of Audit Co...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

medicx fund ltd (MXF) Key Developments

MedicX Fund Limited Announces Executive Changes

MedicX Fund Limited confirmed the retirement of Christopher Bennett from the Board of Directors and as Chairman of the Audit Committee. Steve Le Page, who was appointed to the Board and Audit Committee in November 2014 will assume the role of Chairman of the Audit Committee, effective from December 10, 2014.

Medicx Fund Ltd. Announces Consolidated Unaudited Earnings Results for the Fiscal Year Ended September 30, 2014

Medicx Fund Ltd. announced consolidated unaudited earnings results for the fiscal year ended September 30, 2014. For the year, the company reported total income of £29,488,000 against £25,537,000 a year ago. Profit before interest and tax was £33,425,000 against £20,624,000 a year ago. Profit before tax was £20,436,000 against £9,665,000 a year ago. Profit attributable to equity holders of the parent was £20,172,000 against £9,366,000 a year ago. Earnings per basic and diluted ordinary share were 5.9 pence against 3.6 pence a year ago. Net cash inflow from operating activities was £12,297,000 against £7,020,000 a year ago. Acquisition of investment properties was £16,134,000 against £5,310,000 a year ago. Basic and diluted net asset value per ordinary share was 65.1 pence per ordinary share. Adjusted earnings were £10,724,000 or 3.1 pence per share against £9,522,000 or 3.6 pence per share a year ago. Adjusted net asset value per ordinary basic and diluted share was 65.8 pence against 63.1 pence a year ago. Net debt was £255,182,000 as at September 30, 2014. Total shareholder return of 12.0% for the year against 13.1% a year ago.

Medicx Fund Ltd. Provides Dividend Guidance for the Financial Year Ending September 30, 2015

Medicx Fund Ltd. provided dividend guidance for the financial year ending September 30, 2015. Subject to unforeseen circumstances the Directors expect that the Company will pay dividends totaling 5.9 pence for the financial year ending September 30, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MXF:LN 83.50 GBp -0.25

MXF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MXF.
View Industry Companies

Industry Analysis


Industry Average

Valuation MXF Industry Range
No financial data is available for MXF.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICX FUND LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at